SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wright PK, Marshal J, Desai M. Comparison of SurePath and ThinPrep liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators. Cytopathology. 2010;21:374-378.
  • 2
    Dawson AE. Can we change the way we screen? The ThinPrep Imaging System. Cancer (Cancer Cytopathol). 2004;102:340:344.
  • 3
    Biscotti CV, Dawson AE, Dziura B, et al. Assisted primary screening using the automated ThinPrep Imaging System. Am J Clin Pathol. 2005;123:281-287.
  • 4
    Miller FS, Nagel LE, Kenny-Moynihan MB. Implementation of the ThinPrep Imaging System in a high volume metropolitan laboratory. Diagn Cytopathol. 2007;35:213-217.
  • 5
    Chivukula M, Saad RS, Elishaev E, White S, Mauser N, Dabbs DJ. Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practise [serial online]. Cytojournal. 2007;4:6.
  • 6
    Barroeta JE, Reilly ME, Steinhoff MM, Lawrence WD. Utility of the Thin Prep Imaging System in the detection of squamous intraepithelial abnormalities on retrospective evaluation: can we trust the imager? Diagn Cytopathol. 2012;40:124-127.
  • 7
    Ferraro K, Kanaracus A, Kurian EM. Hologic ThinPrep Imaging System for routine urine screening: evaluation of screening time and diagnostic comparison. Mod Pathol. 2012;25(suppl 2):89A. Abstract 364.
  • 8
    Lauricia R, Bentz JS, Souers RJ, et al. Do liquid-based preparations of urinary cytology perform differently than classically prepared cases. Observations from the College of American Pathologist Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2010;134:19-22.
  • 9
    van Hemel BM, Haarsma JG, Ruitenbeek T, Groen HJ, Suurmeijer AJH. Application of the ThinPrep Imaging System in urine cytology: a prospective study. Cancer (Cancer Cytopathol). 2013;121:410-414.
  • 10
    Halford JA, Batty T, Boost T, et al. Comparison of the sensitivity of conventional cytology and the ThinPrep Imaging System for 1083 biopsy confirmed high-grade squamous lesions. Diagn Cytopathol. 2010;38:318-326.
  • 11
    Roberts JM, Thurloe JK, Bowditch RC, et al. A 3-armed trial of the ThinPrep Imaging System. Diagn Cytopathol. 2007;35:96-102.
  • 12
    Saslow D, Solomon D, Lawson HW, et al. American Cancer Society; American Society for Colposcopy and Cervical Pathology; and American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the Prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-542.
  • 13
    Wright MP, Jones DJ. Surveillance for bladder cancer: the management of 4.8 million people. South West Urologists. BJU Int. 2000;85:431-433.
  • 14
    Yafi FA, Brimo F, Auger M, Aprikian A, Tanguay S, Kassouf W. Is the performance of urine cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer [published online ahead of print February 11, 2013]. Urol Oncol. 2013.
  • 15
    Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practise. J Urol. 2000;163:524-527.
  • 16
    Grossfeld GD, Litwin MS, Wolf JS Jr, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part I: definition, detection, prevalence, and etiology. Urology. 2001;157:599-603.
  • 17
    Grossfeld GD, Litwin MS, Wolf JS Jr, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation and follow-up. Urology. 2001;57:604-610.